We are live on ! Find out more
CCA

Canyon Capital Advisors Portfolio holdings

AUM $772M
1-Year Est. Return 32.81%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+32.81%
3 Year Est. Return
+46.22%
5 Year Est. Return
+58.86%
10 Year Est. Return
+273.66%
AUM
$1.01B
AUM Growth
+$337M
Cap. Flow
+$175M
Cap. Flow %
17.27%
Top 10 Hldgs %
89.63%
Holding
32
New
2
Increased
2
Reduced
1
Closed

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$58.3M

Sector Composition

Rank Sector Weight
1 Energy 31.73%
2 Real Estate 18.25%
3 Materials 17.49%
4 Healthcare 9.2%
5 Consumer Discretionary 5.53%

Similar funds

Canyon Capital Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Canyon Capital Advisors held 32 positions worth $1.01B, up 50% from $677M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Canyon Capital Advisors deployed $175M of net new capital in Q2 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.

By sector, the portfolio is most concentrated in Energy at 32% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $58.3M trimmed.

  • Canyon Capital Advisors's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.
  • Canyon Capital Advisors added most to Seadrill in Q2 2023, an estimated $186M increase.
  • Canyon Capital Advisors's biggest Q2 2023 reduction was Tenet Healthcare, cutting an estimated $58.3M.
  • Canyon Capital Advisors's ten largest holdings make up 90% of its $1.01B portfolio in Q2 2023.
  • Canyon Capital Advisors opened 2 new positions and closed 0 in Q2 2023.
  • Canyon Capital Advisors's portfolio value rose 50% quarter-over-quarter to $1.01B.

Based on Canyon Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.